Recomendaciones para el tratamiento de las pacientes con diabetes pregestacional. Sociedad Argentina de Diabetes - Grupo Latinoamericano de Diabetes y Embarazo
; Glatstein; Liliana ; Sucani, Stella ; Bertona, Celina ; Argerich, Maria Inés ; Gomez Martin, Carolina ; Tedesco, Jorge Fabián ; Capobianco, Evangelina Lorena
; Rivas, Eugenia ; Rodríguez, María Elena ; Basualdo, María Natalia
; Alvariñas, Jorge ; Salzberg, Susana ; Faingold, María Cristina ; Gorban de Lapertosa, Silvia Beatriz ; Rivas Blasco, Aleida ; Rodríguez, María Elena ; Mendes, Patricio ; Marmol, Marta ; Falcon de Legal, Edith ; Ribeiro Gama, Mirnaluci Paulino ; Barbero, Roxana ; Barragán, Derek Otros responsables
Fecha
2018-10-16
Editorial
Asociación Latinoamericana de Diabetes
Revista
Revista de la Alad
Título del libro
Nombre del evento
Fecha del evento
Institución organizadora
ISSN
2248-6518
eISSN
ISBN
Idioma
Español
Tipo del evento
Clasificación temática
Palabras clave
Resumen
La diabetes mellitus (DM) pregestacional afecta al desarrollo de la gestación y se asocia a complicaciones maternas y fetoneonatales. Si bien hace algunos años la mayoría de las pacientes con diabetes pregestacional (DPG) eran diabéticas tipo 1, la prevalencia de mujeres con diabetes tipo 2 en edad reproductiva ha aumentado, asociada al incremento de obesidad. La paciente con DPG con mal control tiene mayor riesgo de complicaciones desde el inicio y hasta el final del embarazo. El control metabólico adecuado, el correcto estado nutricional y el tratamiento de las complicaciones maternas previenen las complicaciones o reducen su severidad. Por ello es fundamental la programación del embarazo para prevenir el daño en las primeras semanas de gestación. Además, es necesario el riguroso seguimiento clínico durante todo el embarazo. En este contexto, mediante el estudio de evidencias científicas y estudios vinculados, surgen estas recomendaciones para mujeres con diabetes pregestacional.
Pregestational DM affects normal gestation and is associated with maternal and fetal-neonatal complications. Although a few years ago most of the patients with pregestational diabetes had type 1 diabetes, the prevalence of type 2 diabetes in women in childbearing age has increased, associated with an increase in obesity. Patients with poorly controlled pregestational diabetes are at higher Pregestational DM affects normal gestation and is associated with maternal and fetal-neonatal complications. Although a few years ago most of the patients with pregestational diabetes had type 1 diabetes, the prevalence of type 2 diabetes in women in childbearing age has increased, associated with an increase in obesity. Patients with poorly controlled pregestational diabetes are at higher risk of complications from the beginning to the end of pregnancy. Adequate metabolic control, proper nutritional status and treatment of maternal complications prevent complications or reduce their severity. For this reason, pregnancy programming is essential to prevent harm from the first weeks of gestation. In addition, rigorous clinical follow-up is required throughout pregnancy. In this context and through the study of scientific evidences and related studies, these recommendations for women with pregestational diabetes emerge.
Pregestational DM affects normal gestation and is associated with maternal and fetal-neonatal complications. Although a few years ago most of the patients with pregestational diabetes had type 1 diabetes, the prevalence of type 2 diabetes in women in childbearing age has increased, associated with an increase in obesity. Patients with poorly controlled pregestational diabetes are at higher Pregestational DM affects normal gestation and is associated with maternal and fetal-neonatal complications. Although a few years ago most of the patients with pregestational diabetes had type 1 diabetes, the prevalence of type 2 diabetes in women in childbearing age has increased, associated with an increase in obesity. Patients with poorly controlled pregestational diabetes are at higher risk of complications from the beginning to the end of pregnancy. Adequate metabolic control, proper nutritional status and treatment of maternal complications prevent complications or reduce their severity. For this reason, pregnancy programming is essential to prevent harm from the first weeks of gestation. In addition, rigorous clinical follow-up is required throughout pregnancy. In this context and through the study of scientific evidences and related studies, these recommendations for women with pregestational diabetes emerge.
Colecciones
Aprobación
Revisión
Complementado por
Referenciado por
Licencia Creative Commons
Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa
